KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Edwards Lifesciences (EW) Raw Materials (2016 - 2025)

Historic Raw Materials for Edwards Lifesciences (EW) over the last 13 years, with Q3 2025 value amounting to $222.8 million.

  • Edwards Lifesciences' Raw Materials fell 1045.02% to $222.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $222.8 million, marking a year-over-year decrease of 1045.02%. This contributed to the annual value of $241.1 million for FY2024, which is 2282.22% up from last year.
  • Edwards Lifesciences' Raw Materials amounted to $222.8 million in Q3 2025, which was down 1045.02% from $249.8 million recorded in Q2 2025.
  • Edwards Lifesciences' Raw Materials' 5-year high stood at $280.0 million during Q1 2024, with a 5-year trough of $196.3 million in Q4 2023.
  • In the last 3 years, Edwards Lifesciences' Raw Materials had a median value of $245.0 million in 2024 and averaged $241.4 million.
  • In the last 5 years, Edwards Lifesciences' Raw Materials surged by 2282.22% in 2024 and then tumbled by 1045.02% in 2025.
  • Quarter analysis of 3 years shows Edwards Lifesciences' Raw Materials stood at $196.3 million in 2023, then grew by 22.82% to $241.1 million in 2024, then dropped by 7.59% to $222.8 million in 2025.
  • Its Raw Materials stands at $222.8 million for Q3 2025, versus $249.8 million for Q2 2025 and $259.2 million for Q1 2025.